DRKS00007783
已完成
不适用
Evaluation of qualified withdrawal treatment in the Klinik North (Hamburg) – a naturalistic study
ASKLEPIOS proresearchKlinische Forschung und Entwicklung0 个研究点目标入组 453 人2015年2月20日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- F10.2
- 发起方
- ASKLEPIOS proresearchKlinische Forschung und Entwicklung
- 入组人数
- 453
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Alcohol dependence according to ICD\-10
- •\- Minimum age of 18 years
- •\- Expected inpatient treatment duration of 20 days
- •\- Written informed consent to take part in the study
排除标准
- •\- Dependence on other substances than alcohol (except nicotine)
- •\- Withdrawal treatment according to 5\- or 10\-days scheme not possible due to mental or somatic comorbidities
- •\- Inability to take part in the study
结局指标
主要结局
未指定
相似试验
招募中
不适用
Effectiveness of medical expulsion therapy for mid and distal ureteric stoneCTRI/2021/01/030864nil
进行中（未招募）
不适用
Strengh and electrical activity measurements of expiratory muscles in neurological subjectsCraniocerebral traumastrokeC10.900.300C10.228.140.300.775RBR-2w526qFaculdade de Ciências Médicas da Universidade Estadual de Campinas (FCM-UNICAMP)
进行中（未招募）
1 期
A randomised controlled trial to compare withdrawal of therapy versus continuing therapy in low disease states in psoriatic arthritis – feasibility studypsoriatic arthritisTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-003736-23-GBniversity of Leeds30
已完成
不适用
Evaluation of withdrawal symptoms and prognosis of eszopiclone - treated chronic insomnia patientschronic insomniaJPRN-UMIN000024462Yoyogi Sleep Disorder Center180
已完成
4 期
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)SpondyloarthritisNCT03253796Merck Sharp & Dohme LLC323